Neuromod Devices, Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Neuromod Devices, Ltd.
Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.
Neuromod Names New CSO To Complete TENT-A Tinnitus Trial And Advance Noninvasive Neuromodulation Platform
Neuromod, a Dublin, Ireland-based emerging medical technology firm focusing on noninvasive neuromodulation technologies, has named neurostimulation expert Hubert Lim as its new CSO to conclude the company's TENT-A tinnitus trial in Ireland and Germany.
Our 12th annual analysis reveals both an expansion of historical patterns of Series A financings and the emergence of a new group of heavily committed, relatively short-term investors.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.
- Medical Devices